Papillary Serous Carcinoma of the Endometrium

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2001

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Endometrial Cancer
Interventions
DRUG

Paclitaxel

50 mg/m\^2 IV over one hour on Day 1, 8, 15, 22, and 29 during radiation therapy followed by 4 additional courses at 135 mg/m\^2 IV over 3 hours every 21 days, 4-6 weeks after pelvic radiation is completed.

RADIATION

Pelvic Radiation

Radiation therapy to the pelvis daily for 25 treatments. Beginning Day 1 or 2 and given for 5 days for 5 weeks, giving a total dose of 45 Gy with external beam radiation to the pelvis. The vaginal apex boost given either with last 3 external beam treatments or after external beam radiation completed for an additional 3 days depending on patient preference. No chemotherapy given with vaginal apex boost.

DRUG

Dexamethasone

20 mg IV given 30 minutes prior to chemotherapy

DRUG

Cimetidine

300 mg IV given 30 minutes prior to chemotherapy

DRUG

Diphenhydramine

50 mg IV given 30 minutes prior to chemotherapy

Trial Locations (2)

32806

M. D. Anderson Cancer Center - Orlando, Orlando

77030

UT MD Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER

NCT00515073 - Papillary Serous Carcinoma of the Endometrium | Biotech Hunter | Biotech Hunter